|4Jan 3, 7:02 PM ET

Fodor William 4

4 · Biostage, Inc. · Filed Jan 3, 2022

Insider Transaction Report

Form 4
Period: 2021-12-29
Fodor William
Chief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-12-29+196,103196,103 total
    Exercise: $2.30Exp: 2031-12-29Common Stock, par value $0.01 per share (196,103 underlying)
Footnotes (1)
  • [F1]Subject to continued employment or service through the applicable vesting dates, these shares vest in four equal amounts on each of the grant date and each anniversary of the grant date.

Documents

1 file
  • 4
    tm221395-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT